Inhibition of angiotensin II receptor binding by quinolone alkaloids from Evodia rutaecarpa

Phytotherapy Research

Volumn 12, Issue 3, 1998, Pages 212-214

  Lee, Hyun Sun ^a   Oh, Won Keun ^a   Choi, Hee Cheol ^a   Lee, Jun Won ^a   Kang, Dae Ook ^a   Park, Chan Sun ^a   Mheen, Tae Ick ^a   Ahn, Jong Seog ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Angiotensin II receptor binding; Evodia rutaecarpa; Quinolone alkaloid; Rutaceae

Indexed keywords

ALKALOID DERIVATIVE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; EVOCARPINE; QUINOLONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; DRUG ISOLATION; DRUG RECEPTOR BINDING; HYPERTENSION; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EVODIA RUTAECARPA;

EID: 0009619553     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199805)12:3<212::AID-PTR216>3.0.CO;2-5     Document Type: Article

References (16)

1. Chen, S. S. T., So, L. T., and White, R. F. (1993). Antihypertensive, fermentatively derived tetrazole derivative and its pharmaceutical use. U.S. Patent 5218125A.
2. Chen, Y., Bean, M. F., and Chambers, C. (1991). Arrivacins, novel pseudoguaiannolide ester with potent angiotensin II binding activity from Ambrosia psilostachya Tetrahedron 47, 4869-4878.
3. Chiou, W., Liao, J., and Chen, C. (1996). Comparative study on the vasodilatory effect of three quinazoline alkaloids isolated from Evodia rutaecarpa. J. Nat. Prod. 59, 374-378.
4. Dudley, D. T., Panek, R. L., and Major, T. C. (1990). Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38, 370-377.
5. Erdoes, E. G., and Skidgel, R. A. (1986). The unusual substrate specificity and the distribution of human angiotensin I converting enzyme. Special lecture. Hypertension 8, 40-48.
6. Haji, A., Momose, Y., Takeda, R., and Nakanishi, S. (1994). Increased feline cerebral blood flow induced by dehydroevodiamine hydrochloride from Evodia rutaecarpa. J. Nat. Prod. 57, 387-398.
7. Ishimaru, T., Harada, S., and Tsuboya, S. (1993). TAN 1446 exhibiting anti-angiotensin II activity and its manufacture with Penicillium restrictum. JP 05041994.
8. King, C. L., Kong, Y. C., Wong, N. S., Yeung, H. W., Fong, H. H. S., and Sankawa, U. (1980). Uterotonic effect of Evodia rutaecarpa alkaloids. J. Nat. Prod. 43, 577-582.
9. Skidgel, R. A., and Erdoes, E. G. (1987). The broad substrate specificity of human angiotensin I converting enzyme. Clin. Exp. Hypertens. A9, 2243.
10. Slate, D. L., Lee, R. H., Rodriguez, and Crews, P. (1994). The marine natural product, halistanol trisulfate, inhibits pp60v src protein tyrosine kinase activity. Biochem. Biophys. Res. Commun. 203, 260-264.
11. Smith, R. D., Chiu, A. T., Wong, P. C., Herblin, W. F., and Timmermans, P. (1992). Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32, 135-165.
12. Stevens-Miles, S., Goetz, M. A., and Bills, G. F. (1996). Discovery of an angiotensin II binding inhibitor from a Cytospora sp. using semi-automated screening procedures. J. Antibiot. 49, 119-123.
13. Sugimoto, T., Miyase, T., Kuroyanagi, M., and Ueno, A. (1988). Limonoids and quinolone alkaloids from Evodia rutaecarpa Benth. Chem. Pharm. Bull. 36, 4453-4461.
14. Tang, W., and Eisenbrand, G. (1992). Chinese Drugs of Plant Origin, pp. 509-514. Springer-Verlag, Berlin, Heidelberg.
15. Tang, Y.-Q., Feng, X.-Z., and Huang, L. (1996). Quinolone alkaloids from Evodia rutaecarpa. Phytochemistry 43, 719-722.
16. Vallotton, M. B. (1987). The renin-angiotensin system. TIPS 8, 69-74.